What is Ziplyft?
Ziplyft, operating within the medical device industry, specializes in innovative eyelid procedures. Their patented Ziplyft device offers a minimally invasive solution for lid lifts, aiming to enhance both vision and appearance while reducing recovery time and patient discomfort. The company targets both surgeons seeking to expand their service offerings and patients desiring effective, less invasive cosmetic surgery options. OSHERU's mission is to revolutionize eyelid surgery, making it more accessible and efficient.
How much funding has Ziplyft raised?
Ziplyft has raised a total of $4.7M across 1 funding round:
Angel/Seed
$4.7M
Angel/Seed (2024): $4.7M with participation from Phil Knight and Laboratorios Sophia
Key Investors in Ziplyft
Phil Knight
Phil Knight is a freelance GIS specialist with extensive experience in geospatial information management, providing services in systems development, cartography, and data analysis for international organizations. His expertise is valuable for mapping agencies and NGOs.
Laboratorios Sophia
Sophia Innovation Capital is a company operating in the Pharmaceuticals industry, with significant revenue and a substantial employee base, indicating a strong presence in the sector.
What's next for Ziplyft?
The recent major strategic investment in Ziplyft signals a pivotal growth phase, likely enabling the company to scale its operations, further develop its patented Ziplyft device, and expand its market reach. This enterprise-level backing suggests a focus on accelerating product development and commercialization, positioning Ziplyft for significant advancements in the field of ophthalmic and cosmetic surgery.
See full Ziplyft company page
